Biotech stock -- AUXL# Stock
g*e
1 楼
Current price: $16.9
Catalyst evetn: Auxilium Pharmaceuticals, Inc. at Goldman Sachs Healthcare
Conference - 1:40PM EDT Jun 13, 2013
Its price is at Bottom with further big catalyst event:
Xiaflex indication for Peyronie's disease have PDUFA on 09/06/2013.
Also recent analyst updates:
Leerink upgraded Auxilium citing accretion from the Actient acquisition and
optimism for FDA approval of Xiaflex in Peyronie's disease. The firm raised
its price target for shares to $21 from $16.
Do your own DD before investing. Good luck!!
Catalyst evetn: Auxilium Pharmaceuticals, Inc. at Goldman Sachs Healthcare
Conference - 1:40PM EDT Jun 13, 2013
Its price is at Bottom with further big catalyst event:
Xiaflex indication for Peyronie's disease have PDUFA on 09/06/2013.
Also recent analyst updates:
Leerink upgraded Auxilium citing accretion from the Actient acquisition and
optimism for FDA approval of Xiaflex in Peyronie's disease. The firm raised
its price target for shares to $21 from $16.
Do your own DD before investing. Good luck!!